Jason Luoma, Ph.D.
banner
jasonluoma.bsky.social
Jason Luoma, Ph.D.
@jasonluoma.bsky.social
Psychedelics, MDMA, and shame researcher, treatment developer, author, psychologist, and therapy trainer, at the Portland Institute for Psychedelic Science.
First year they asked about psilocybin specifically, so we'll get some trend data in future years.
July 30, 2025 at 8:18 AM
Psychedelics use continues to increase in the USA among people over 25 years old (not for younger cohorts, with a drop in later adolescents. [from 2024 National Survey on Drug Use and Health]
July 30, 2025 at 8:18 AM
I was just interviewed on the Practice of the Practice Podcast about psychedelics. Fun interview covering a range of topics around psychedelic-assisted therapy, e.g., how PAT will eventually integrate with our healthcare system in the US. @psychedelicscience podcasts.apple.com/us/podcast/t...
March 4, 2025 at 10:02 PM
Just found this newspaper clipping from when my grandfather was in the hospital with polio. He was fortunate to survive and live most of his life in a wheelchair. It was a vivid reminder of the times before widespread vaccination where healthy people frequently succumbed to bacteria and viruses.
March 2, 2025 at 4:48 PM
Data from hundreds of experience reports shows a clear pattern: The initial phase often brings:

Anxiety
Nausea
Physical tension
Mental confusion
Behavioral immobility

While the come-down typically brings:

Peace
Clarity
Social connection
Gratitude
February 11, 2025 at 3:56 PM
I'm very excited to be speaking at the International Society for Research on Psychedelics virtual conference taking place on March 7th. The event features presentations by 27 of the world's top psychedelic researchers, and you can find out more and register at: www.isrpsych.org/conferences.
February 4, 2025 at 5:51 PM